Improvement of the recurrence-free interval using biological adjuvant therapy in uveal melanoma

Anticancer Research

Volumn 20, Issue 3 B, 2000, Pages 1969-1975

  Tallberg, Thomas ^c   Uusitalo, R ^d   Sarna, S ^d   Seregard, S ^a   Werschnik, C ^b  

^a ST ERIK S EYE HOSPITAL   (Sweden)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c Institute of Bio Immunotherapy   (Finland)

^d NONE

Author keywords

Active specific immunotherapy; Adjuvant biotherapy; Melanoma recurrency rate; Melanoma survival rate; Uveal melanoma

Indexed keywords

AMINO ACID; FOLIC ACID; LIPID; TRACE ELEMENT;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; DIET THERAPY; DRUG COST; ENUCLEATION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MALE; PRIORITY JOURNAL; SIDE EFFECT; UVEA MELANOMA;

ADMINISTRATION, ORAL; ADULT; AGED; AMINO ACIDS; ANIMALS; BRACHYTHERAPY; BRAIN; CANCER VACCINES; CHOROID NEOPLASMS; COMBINED MODALITY THERAPY; DIETARY FATS; DIETARY SUPPLEMENTS; EYE ENUCLEATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOTHERAPY; INFLUENZA VACCINES; MALE; MEAT; MELANOMA; MIDDLE AGED; PILOT PROJECTS; SURVIVAL ANALYSIS; SWINE; TRACE ELEMENTS; TREATMENT OUTCOME; VITAMINS;

EID: 0033884256     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Summanen P, Immonen I, Heikkonen J, Tommila P, Laatikainen L, Tarkkanen A: Survival of patients and metastatis and local recurrent tumor growth in malignant melanoma of the uvea after ruthenium plaque radiotherapy. Opthalmic Surg 24: 82-90, 1993.
2. Gragoudas ES, Egan KM, Seddon JM, et al: Survival of patients with metastases from uveal melanoma. Ophthalmology 98: 383-390, 1991.
3. Tallberg T, Kalima T, Halttunen P, Tykkä H, Mahlberg K, Matous and Sundell: Postoperative active specific immunotherpay with supportive measures in patients suffering from recurrent metastasized melanoma: Case report of six patients. J Surg Oncol 33: 115-119, 1986.
4. Tallberg T, Matous B, Tykkä H, Vosmik Fr, Sarna S, Bauer J, Krajsova I, Sundell B: Malignant Melanoma. Effect of post-operative specific immunotherapy and dietary supplementation on progress and prognosis. Tumordiagn u Ther 12: 139-146, 1991.
5. Tallberg T, Uusitalo R : Study of the effect of biological nutritional supplementation on the recurrency rate of ocular melanoma. Zeitschr Oncol / J of Oncol 29: 1-6, 1997.
6. Lommatzsch PK: Results after b-irradiation (106RU/106Rh) of choroidal melanomas: 20 years' experience. Brit J Ophthalmol 70: 844-851, 1986.
7. Avrameas S, Ternynct T: Biologically active water insoluble protein polymers. Their use for isolation of antigens and antibodies. J Biol Chem 242: 1651-1659, 1967.